Publications by authors named "Leo Essl"

Claim this Profile
E
Exceptional sustained long-term complete response to Tepotinib in a MET-amplified advanced intrahepatic biliary tract cancer failing Durvalumab plus Cisplatin and Gemcitabine.
Andreas Reichinger, Leo Essl, Paul Kerschner, Jonathan Burghofer, Gerald Webersinke

Oncologistยท December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis